Cornercap Investment Counsel Inc. Sells 7,316 Shares of Maximus, Inc. (NYSE:MMS)

Cornercap Investment Counsel Inc. trimmed its position in shares of Maximus, Inc. (NYSE:MMSFree Report) by 54.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,173 shares of the health services provider’s stock after selling 7,316 shares during the period. Cornercap Investment Counsel Inc.’s holdings in Maximus were worth $575,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of MMS. V Square Quantitative Management LLC bought a new stake in shares of Maximus during the 3rd quarter valued at $25,000. GAMMA Investing LLC grew its stake in shares of Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after buying an additional 238 shares in the last quarter. Blue Trust Inc. grew its stake in shares of Maximus by 201.5% in the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock worth $33,000 after buying an additional 262 shares in the last quarter. Archer Investment Corp boosted its stake in shares of Maximus by 8,788.9% during the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after purchasing an additional 791 shares during the period. Finally, Ariadne Wealth Management LP purchased a new position in shares of Maximus during the 2nd quarter worth about $90,000. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

MMS stock opened at $79.18 on Friday. Maximus, Inc. has a 12 month low of $76.42 and a 12 month high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. The company has a 50-day moving average price of $89.02 and a 200 day moving average price of $88.11. The stock has a market cap of $4.77 billion, a PE ratio of 16.60 and a beta of 0.77.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.52%. Maximus’s dividend payout ratio is presently 25.16%.

Insider Buying and Selling

In other Maximus news, insider Michelle F. Link sold 1,363 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at $607,841.52. The trade was a 17.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.40% of the stock is owned by corporate insiders.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.